V. Väisänen

898 total citations
8 papers, 687 citations indexed

About

V. Väisänen is a scholar working on Molecular Biology, Endocrinology and Genetics. According to data from OpenAlex, V. Väisänen has authored 8 papers receiving a total of 687 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 4 papers in Endocrinology and 2 papers in Genetics. Recurrent topics in V. Väisänen's work include Escherichia coli research studies (4 papers), Glycosylation and Glycoproteins Research (3 papers) and Viral gastroenteritis research and epidemiology (1 paper). V. Väisänen is often cited by papers focused on Escherichia coli research studies (4 papers), Glycosylation and Glycoproteins Research (3 papers) and Viral gastroenteritis research and epidemiology (1 paper). V. Väisänen collaborates with scholars based in Finland, Sweden and Germany. V. Väisänen's co-authors include T K Korhonen, S. B. Svenson, Hans Hultberg, Mark Achtman, P. Helena Mäkelä, Jaakko Elo, L G Tallgren, Timo Korhonen, Harri Saxén and Gunilla Källenius and has published in prestigious journals such as The Lancet, Biochemical and Biophysical Research Communications and Antimicrobial Agents and Chemotherapy.

In The Last Decade

V. Väisänen

8 papers receiving 560 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
V. Väisänen Finland 8 398 237 216 129 98 8 687
F Orskov Sweden 12 421 1.1× 220 0.9× 160 0.7× 118 0.9× 42 0.4× 15 640
S.J. Hultgren United States 9 417 1.0× 351 1.5× 201 0.9× 260 2.0× 46 0.5× 12 782
B I Eisenstein United States 14 352 0.9× 248 1.0× 81 0.4× 124 1.0× 21 0.2× 15 619
В. Л. Чеснокова United States 6 320 0.8× 250 1.1× 105 0.5× 129 1.0× 18 0.2× 11 574
Matt S. Conover United States 15 298 0.7× 429 1.8× 392 1.8× 135 1.0× 65 0.7× 20 909
Daniël J. Wurpel Australia 9 276 0.7× 206 0.9× 189 0.9× 83 0.6× 36 0.4× 11 522
Robert J. Roantree United States 13 230 0.6× 152 0.6× 104 0.5× 98 0.8× 7 0.1× 21 722
Michael J. Cieslewicz United States 11 101 0.3× 278 1.2× 581 2.7× 127 1.0× 23 0.2× 11 1.2k
C Hammack United States 9 186 0.5× 184 0.8× 169 0.8× 85 0.7× 7 0.1× 10 697
Patrick D. Olson United States 8 152 0.4× 344 1.5× 154 0.7× 127 1.0× 46 0.5× 11 623

Countries citing papers authored by V. Väisänen

Since Specialization
Citations

This map shows the geographic impact of V. Väisänen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by V. Väisänen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites V. Väisänen more than expected).

Fields of papers citing papers by V. Väisänen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by V. Väisänen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by V. Väisänen. The network helps show where V. Väisänen may publish in the future.

Co-authorship network of co-authors of V. Väisänen

This figure shows the co-authorship network connecting the top 25 collaborators of V. Väisänen. A scholar is included among the top collaborators of V. Väisänen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with V. Väisänen. V. Väisänen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Elo, Jaakko, L G Tallgren, V. Väisänen, et al.. (1985). Association of P and other Fimbriae with Clinical Pyelonephritis in Children. Scandinavian Journal of Urology and Nephrology. 19(4). 281–284. 24 indexed citations
2.
Kušećek, Barica, Andrew A. Mercer, V. Väisänen, et al.. (1984). Lipopolysaccharide, capsule, and fimbriae as virulence factors among O1, O7, O16, O18, or O75 and K1, K5, or K100 Escherichia coli. Infection and Immunity. 43(1). 368–379. 87 indexed citations
3.
Waalen, K., et al.. (1983). TheN-terminal amino acid sequence of type 1 fimbria (pili) ofSalmonella typhimuriumLT2. FEMS Microbiology Letters. 16(2-3). 149–151. 12 indexed citations
4.
Parkkinen, J, Jukka Finne, Mark Achtman, V. Väisänen, & T K Korhonen. (1983). Escherichia coli strains binding neuraminyl α2–3 galactosides. Biochemical and Biophysical Research Communications. 111(2). 456–461. 121 indexed citations
5.
Väisänen, V., Kari Lounatmaa, & T K Korhonen. (1982). Effects of sublethal concentrations of antimicrobial agents on the hemagglutination, adhesion, and ultrastructure of pyelonephritogenic Escherichia coli strains. Antimicrobial Agents and Chemotherapy. 22(1). 120–127. 24 indexed citations
6.
Hovi, Tapani, V. Väisänen, Pentti Ukkonen, & Carl‐Henrik von Bonsdorff. (1982). Solid-phase enzyme immunoassay for rotavirus antigen: Faecal protease activity as a reason for false-negative results. Journal of Virological Methods. 5(1). 45–53. 20 indexed citations
7.
Korhonen, T K, V. Väisänen, Harri Saxén, Hans Hultberg, & S. B. Svenson. (1982). P-antigen-recognizing fimbriae from human uropathogenic Escherichia coli strains. Infection and Immunity. 37(1). 286–291. 136 indexed citations
8.
Väisänen, V., L G Tallgren, P. Helena Mäkelä, et al.. (1981). MANNOSE-RESISTANT HAEMAGGLUTINATION AND P ANTIGEN RECOGNITION ARE CHARACTERISTIC OF ESCHERICHIA COLI CAUSING PRIMARY PYELONEPHRITIS. The Lancet. 318(8260-8261). 1366–1369. 263 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026